Neopterin as a potential modulator of tumor cell growth and proliferation

Medical Hypotheses

Volumn 60, Issue 4, 2003, Pages 531-534

  Rieder, Josef ^a   Lirk, Philipp ^a   Hoffmann, Georg ^b  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; NEOPTERIN; NITRIC OXIDE;

APOPTOSIS; ARTICLE; BLOOD LEVEL; CANCER PATIENT; CELL PROLIFERATION; CORRELATION ANALYSIS; HUMAN; INFECTION; METASTASIS; PRIORITY JOURNAL; TUMOR GROWTH;

EID: 0037375886     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-9877(03)00002-1     Document Type: Article

References (26)

1. Fuchs D., Weiss G., Reibnegger G., Wachter H. The role of neopterin as a monitor of cellular immune activation in transplantation, inflammatory, infectious, and malignant diseases. Crit Rev Clin Lab Sci 1992; 29: 307-341.
2. Hausen A., Fuchs D., Grünewald K., Huber H., König K., Wachter H. Urinary neopterine as marker for haematological neoplasias. Clin Chim Acta 1981; 117: 297-305.
3. Antoniello S., Auletta M., Magri P., Russo N. Serum neopterin levels in patients with hepatocellular carcinoma. Biol Chem Hoppe Seyler 1992; 373: 1165-1168.
4. Frick J., Aulitzky W., Fuchs D. et al. The value of urinary neopterin as an immunological parameter in patients with malignant tumors of the genitourinary tract. Urol Int 1985; 40: 155-159.
5. Reibnegger G., Hetzel H., Fuchs D. et al. Clinical significance of neopterin for prognosis and follow-up in ovarian cancer. Cancer Res 1987; 47: 4977-4981.
6. Haeger M., Swahn M., Hahlin M., Horvath G., Bengtsson A. Increased concentrations of neopterin in plasma, ascites and ovarian cyst fluid in malignant tumours compared with benign ovarian tumours. Anticancer Res 1996; 16: 3189-3192.
7. Marth C., Weger A., Müller H. E. et al. The prognostic value of nuclear roundness and neopterin in ovarian cancer. Eur J Cancer A 1993; 29: 1863-1868.
8. Wede I., Semenitz E., Wachter H., Fuchs D. Neopterin and 7,8-dihydroneopterin modulate microbicidal effects of reactive oxygen and chlorine species on Escherichia coli. Pteridines 1996; 7: 64-65.
9. Weiss G., Fuchs D., Hausen A. et al. Neopterin modulates toxicity mediated by reactive oxygen and chloride species. FEBS Lett 1993; 321: 89-92.
10. Widner B., Baier-Bitterlich G., Wede I., Wirleitner B., Fuchs D. Neopterin derivatives modulate the nitration of tyrosine by peroxynitrite. Biochem Biophys Res Cornmun 1998; 248: 341-346.
11. Schobersberger W., Hoffmann G., Grote J., Wachter H., Fuchs D. Induction of inducible nitric oxide synthase expression by neopterin in vascular smooth muscle cells. FEBS Lett 1995; 377: 461-464.
12. Hoffmann G., Schobersberger W., Frede S. et al. Neopterin activates transcription factor nuclear factor-κB in vascular smooth muscle cells. FEBS Lett 1996; 391: 181-184.
13. Hoffmann G., Frede S., Kenn S. et al. Neopterin-induced tumor necrosis factor-α synthesis in vascular smooth muscle cells in vitro. Int Arch Allergy Immunol 1998; 116: 240-245.
14. Thompson C. B. Apoptosis in the pathogenesis and treatment of disease. Science 1995; 267: 1456-1462.
15. Hoffmann G., Kenn S., Wirleitner B. et al. Neopterin induces nitric oxide-dependent apoptosis in rat vascular smooth muscle cells. Immunobiology 1998; 199: 63-73.
16. Schobersberger W., Hoffmann G., Hobisch H. P. et al. Neopterin and 7,8-dihydroneopterin induce apoptosis in the rat alveolar epithelial cell line L2. FEBS Lett 1996; 397: 263-268.
17. Baier-Bitterlich G., Fuchs D., Murr C. et al. Effect of neopterin and 7,8-dihydroneopterin on tumor necrosis factor-α induced programmed cell death. FEBS Lett 1995; 364: 234-238.
18. Rieder J., Marth C., Totzke G., Smolny M., Seibel M., Hoffmann G. Different patterns of inducible nitric oxide synthase gene expression in ovarian carcinoma cell lines. Anticancer Res 2000; 20: 3251-3258.
19. Andrade S. P., Hart I. R., Piper P. J. Inhibitors of nitric oxide synthase selectively reduce flow in tumor-associated neovasculature. Br J Pharmacol 1992; 107: 1092-1095.
20. Pipili-Synetos E., Papageorgiou A., Sakkoula E. et al. Inhibition of angiogenesis, tumour growth and metastasis by the NO-releasing vasodilators, isosorbide mononitrate and dinitrate. Br J Pharmacol 1995; 116: 1829-1834.
21. Rieder J., Jahnke R., Schloesser M. et al. Nitric oxide-dependent apoptosis in ovarian carcinoma cell lines. Gynecol Oncol 2001; 82: 172-176.
22. Rieder J., Amann A., Schloesser M. et al. Suppressive effects of neopterin on inducible nitric oxide synthase gene expression in ovarian carcinoma cells in vitro. Pteridines 2001; 12: 1-8.
23. Mesiano S., Ferrara N., Jaffe R. B. Role of vascular endothelial growth factor in ovarian cancer: inhibition of ascites formation by immunoneutralization. Am J Pathol 1998; 153: 1249-1256.
24. Anagnostou A., Liu Z., Steiner M. et al. Erythropoietin receptor mRNA expression in human endothelial cells. Proc Natl Acad Sci USA 1994; 91: 3974-3978.
25. Anagnostou A., Lee E. S., Kessimian N., Levinson R., Steiner M. Erythropoietin has a mitogenic and positive chemotactic effect on endothelial cells. Proc Natl Acad Sci USA 1990; 87: 5978-5982.
26. Schobersberger W., Jelkmann W., Fandrey F., Frede S., Wachter H., Fuchs D. Neopterin-induced suppression of erythropoietin production in vitro. Pteridines 1995; 8: 12-16.